20
Ckd Bio Corporation Sapgyo-eup Kr, based in South Korea, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Everolimus, 2.0% BHT, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2019-321 - Rev 01
This Chemical Type CEP, issued on November 30, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2918 associated with this CEP further emphasizes